ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2010 | 13.68 Million USD | 83.43% |
| 2009 | 7.45 Million USD | 21867.85% |
| 2008 | -34.26 Thousand USD | -179.96% |
| 2007 | 42.85 Thousand USD | 477.26% |
| 2006 | -11.35 Thousand USD | 77.92% |
| 2005 | -51.44 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2011 Q1 | 3.72 Million USD | -9.03% |
| 2011 Q3 | 3.06 Million USD | -22.07% |
| 2011 Q2 | 3.93 Million USD | 5.72% |
| 2010 Q4 | 4.09 Million USD | 30.83% |
| 2010 Q3 | 3.13 Million USD | -12.16% |
| 2010 FY | 13.68 Million USD | 83.43% |
| 2010 Q1 | 2.89 Million USD | -27.43% |
| 2010 Q2 | 3.56 Million USD | 23.18% |
| 2009 FY | 7.45 Million USD | 21867.85% |
| 2009 Q4 | 3.98 Million USD | 167.33% |
| 2009 Q3 | 1.49 Million USD | 2077.4% |
| 2009 Q1 | -12.79 Thousand USD | -170.34% |
| 2009 Q2 | -75.4 Thousand USD | -489.23% |
| 2008 Q1 | -4383.00 USD | -109.19% |
| 2008 FY | -34.26 Thousand USD | -179.96% |
| 2008 Q4 | 18.19 Thousand USD | 151.48% |
| 2008 Q2 | -21.52 Thousand USD | -390.99% |
| 2008 Q3 | -35.33 Thousand USD | -64.21% |
| 2007 FY | 42.85 Thousand USD | 477.26% |
| 2007 Q4 | 47.68 Thousand USD | 65.67% |
| 2007 Q1 | -35.07 Thousand USD | -2701.13% |
| 2007 Q3 | 28.78 Thousand USD | 729.87% |
| 2007 Q2 | -4570.00 USD | 86.97% |
| 2006 Q1 | -5642.98 USD | 0.0% |
| 2006 Q2 | -6635.06 USD | -17.58% |
| 2006 Q3 | 2170.70 USD | 132.72% |
| 2006 Q4 | -1252.31 USD | -157.69% |
| 2006 FY | -11.35 Thousand USD | 77.92% |
| 2005 FY | -51.44 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 1124.504% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 371.218% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 176.66% |
| Nascent Biotech, Inc. | -2.22 Million USD | 713.556% |
| Rebus Holdings, Inc. | -664 Thousand USD | 2160.474% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 83.285% |
| Qrons Inc. | -643.67 Thousand USD | 2225.53% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 3611.962% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 124.648% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 3392.958% |
| Skye Bioscience, Inc. | -13.67 Million USD | 200.071% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 119.059% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -178.374% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 5327.432% |
| SQZ Biotechnologies Company | -75.82 Million USD | 118.044% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 579.969% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 990.697% |
| Mesoblast Limited | -84.14 Million USD | 116.259% |
| Marizyme, Inc. | -34.08 Million USD | 140.138% |
| Genus plc | 6.4 Million USD | -113.774% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | -40.432% |
| Pharming Group N.V. | -4.87 Million USD | 380.386% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 788.734% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 1568.955% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 263.851% |
| ContraFect Corporation | -56.88 Million USD | 124.05% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 400.381% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 1075.866% |
| IMV Inc. | -38.67 Million USD | 135.379% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 597.359% |
| MultiCell Technologies, Inc. | -722.81 USD | 1892927.852% |
| Accustem Sciences Inc. | -3.74 Million USD | 465.19% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 123.193% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | 2932.255% |
| Q BioMed Inc. | -3.44 Million USD | 497.071% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | -286.484% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 620.702% |
| Biomind Labs Inc. | -1 Million USD | 1455.141% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 124.888% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 571.574% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 305.799% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 833.843% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | 45778.249% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 186.212% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 807.931% |
| GB Sciences, Inc. | -1.42 Million USD | 1063.144% |
| Alpha Cognition Inc. | -9.7 Million USD | 240.966% |
| HST Global, Inc. | -140.9 Thousand USD | 9809.63% |
| CSL Limited | 3.7 Billion USD | 99.63% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 1316.239% |
| Halberd Corporation | -75.05 Thousand USD | 18329.912% |
| Enzolytics Inc. | -2.14 Million USD | 736.706% |
| Agentix Corp. | -1.37 Million USD | 1097.375% |
| Resverlogix Corp. | -12.74 Million USD | 207.315% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 531.83% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -425.04 Million USD | 103.219% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 1410.493% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 568.635% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 966.274% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 501.81% |
| AVAX Technologies, Inc. | 6.69 Million USD | -104.419% |
| Zenith Capital Corp. | -8.94 Million USD | 252.986% |
| Genscript Biotech Corporation | -415.79 Million USD | 103.29% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 78634.809% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 657.221% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 8077.136% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 782.454% |
| Kadimastem Ltd | -3.04 Million USD | 550.014% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 1490.326% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 1189.295% |
| BioStem Technologies, Inc. | -7.77 Million USD | 275.879% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 7638.667% |
| LadRx Corporation | -3.82 Million USD | 457.816% |
| Cell Source, Inc. | -4.32 Million USD | 416.311% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 2091.637% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 2091.637% |
| NovAccess Global Inc. | -2.46 Million USD | 654.636% |
| Affymax, Inc. | -15.04 Million USD | 190.931% |
| Itoco Inc. | -919.14 Thousand USD | 1588.516% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 422.799% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 1322.659% |
| Mobile Lads Corp. | -554.55 Thousand USD | 2567.144% |
| CytoDyn Inc. | -18.05 Million USD | 175.764% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | 54456.571% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 6316.682% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 2522.701% |
| SYBLEU INC | -149.18 Thousand USD | 9271.168% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 853.257% |
| International Stem Cell Corporation | -663 Thousand USD | 2163.582% |
| Bioxytran, Inc. | -3.82 Million USD | 458.142% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 26090.785% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | 67364.253% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 137.726% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 945.584% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 1959.323% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 539.78% |
| Neutra Corp. | -229.48 Thousand USD | 6061.823% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 178.006% |
| PureTech Health plc | -146.19 Million USD | 109.358% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 163.661% |
| IXICO plc | -1.43 Million USD | 1052.091% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 244.153% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 111.232% |
| CSL Limited | 3.81 Billion USD | 99.641% |
| Cellectis S.A. | -108.85 Million USD | 112.568% |